Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India · Delayed Price · Currency is INR 557.55
+6.05 (1.10%)
At close: Jul 15, 2025
BOM:544222 Revenue
In the fiscal year ending March 31, 2025, Akums Drugs and Pharmaceuticals had annual revenue of 41.21B INR, down -1.45%. Akums Drugs and Pharmaceuticals had revenue of 10.59B in the quarter ending March 31, 2025, with 11.69% growth.
Revenue
41.21B
Revenue Growth
-1.45%
P/S Ratio
2.09
Revenue / Employee
5.47M
Employees
7,536
Market Cap
85.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 41.21B | -605.31M | -1.45% |
| Mar 31, 2024 | 41.82B | 5.24B | 14.34% |
| Mar 31, 2023 | 36.57B | -180.32M | -0.49% |
| Mar 31, 2022 | 36.75B | 9.49B | 34.81% |
| Mar 31, 2021 | 27.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |